Library Catalog
Amazon cover image
Image from Amazon.com

Pandemic Medicine : Why the Global Innovation System Is Broken, and How We Can Fix It / Kathryn C. Ibata-Arens.

By: Material type: TextTextSeries: Advances in International Political EconomyPublisher: Boulder : Lynne Rienner Publishers, [2022]Copyright date: ©2021Description: 1 online resource (217 p.)Content type:
Media type:
Carrier type:
ISBN:
  • 9781626379695
  • 9781685851033
Subject(s): DDC classification:
  • 615.1/9 23
LOC classification:
  • RM301.25 I23 2021
Other classification:
  • online - DeGruyter
Online resources:
Contents:
Frontmatter -- Contents -- Acknowledgments -- 1 An Innovation Commons: The Global System for New Drug Discovery -- 2 Twilight of the (Big Pharma) Gods: The Rise and Decline of Innovation -- 3 Books of Remedies: China’s Drug (Re)Discovery Politics -- 4 The Turmeric War: India Takes on the World Trade Organization and Big Pharma -- 5 Medicine Gardens: Japan’s Investment in New Drug Discovery -- 6 A Way Forward: Bringing Innovative Solutions to Global Human Health Problems -- Acronyms -- References -- Index -- About the Book
Summary: Despite a century of advances in modern medicine, as well as the rapid development of Covid vaccines, the global pharmaceutical industry has largely failed to bring to market drugs that actually cure disease. Why? And looking further . How can government policies stimulate investment in the development of curative drugs? Is there an untapped potential for "natural medicines" in new drug discovery? How have private–public sector partnerships transformed the ways we innovate? To what extent are medicinal plant biodiversity and human health codependent? Addressing this range of increasingly critical questions, Kathryn Ibata-Arens analyzes the rise and decline of the global innovation system for new drug development and proposes a policy framework for fast-tracking the implementation of new discoveries and preparing for future pandemics.
Holdings
Item type Current library Call number URL Status Notes Barcode
eBook eBook Biblioteca "Angelicum" Pont. Univ. S.Tommaso d'Aquino Nuvola online online - DeGruyter (Browse shelf(Opens below)) Online access Not for loan (Accesso limitato) Accesso per gli utenti autorizzati / Access for authorized users (dgr)9781685851033

Frontmatter -- Contents -- Acknowledgments -- 1 An Innovation Commons: The Global System for New Drug Discovery -- 2 Twilight of the (Big Pharma) Gods: The Rise and Decline of Innovation -- 3 Books of Remedies: China’s Drug (Re)Discovery Politics -- 4 The Turmeric War: India Takes on the World Trade Organization and Big Pharma -- 5 Medicine Gardens: Japan’s Investment in New Drug Discovery -- 6 A Way Forward: Bringing Innovative Solutions to Global Human Health Problems -- Acronyms -- References -- Index -- About the Book

restricted access online access with authorization star

http://purl.org/coar/access_right/c_16ec

Despite a century of advances in modern medicine, as well as the rapid development of Covid vaccines, the global pharmaceutical industry has largely failed to bring to market drugs that actually cure disease. Why? And looking further . How can government policies stimulate investment in the development of curative drugs? Is there an untapped potential for "natural medicines" in new drug discovery? How have private–public sector partnerships transformed the ways we innovate? To what extent are medicinal plant biodiversity and human health codependent? Addressing this range of increasingly critical questions, Kathryn Ibata-Arens analyzes the rise and decline of the global innovation system for new drug development and proposes a policy framework for fast-tracking the implementation of new discoveries and preparing for future pandemics.

Mode of access: Internet via World Wide Web.

In English.

Description based on online resource; title from PDF title page (publisher's Web site, viewed 02. Mai 2023)